The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma-Reference-Cited by-同舟云学术

The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma

Published:2021-10 Issue: Volume:519 Page:250-262
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Augello Giuseppa,Emma Maria Rita,Azzolina Antonina,Puleio Roberto^ORCID,Condorelli Lucia,Cusimano Antonella,Giannitrapani Lydia,McCubrey James A.^ORCID,Iovanna Juan Lucio,Cervello Melchiorre^ORCID

Funder

Associazione Italiana per la Ricerca sul Cancro

Airc Italian Foundation for Cancer Research

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference53 articles.

1. Targeted therapy for hepatocellular carcinoma: novel agents on the horizon;Cervello;Oncotarget,2012

2. New landscapes and horizons in hepatocellular carcinoma therapy;Cervello;Aging,2020

3. Intratumor heterogeneity in hepatocellular carcinoma;Friemel;Clin. Canc. Res.,2015

4. Heterogeneity of liver cancer and personalized therapy;Li;Canc. Lett.,2016

5. Molecular mechanisms of sorafenib action in liver cancer cells;Cervello;Cell Cycle,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SCARB1‐encoded circ _0029343 induces p73 splicing to promote growth and metastasis of hepatocellular carcinoma via miR‐486‐5p/SRSF3 axis;Journal of Biochemical and Molecular Toxicology;2024-02

2. NUPR1 contributes to activate TFE3-dependent autophagy leading to cervical cancer proliferation;Heliyon;2024-01

3. Insights from a Computational-Based Approach for Analyzing Autophagy Genes across Human Cancers;Genes;2023-07-28

4. Mechanism of NURP1 in temozolomide resistance in hypoxia-treated glioma cells via the KDM3A/TFEB axis;Oncology Research;2023

5. Drug Resistance in Hepatocellular Carcinoma;Interdisciplinary Cancer Research;2023